DLP High Flow Coronary Artery Ostial Cannulae (Models 30155,30255) - Cannula, coronary artery Australien - engelska - Department of Health (Therapeutic Goods Administration)

dlp high flow coronary artery ostial cannulae (models 30155,30255) - cannula, coronary artery

medtronic australasia pty ltd - 34896 - cannula, coronary artery - coronary cannulae consist of a basket-style tip, soft (silicone) tip, or spherical tip which is attached to a malleable stainless steel tube, or a soft-bulb, beveled tip with an integral silicone body. the cannulae terminate with a locking female luer fitting. the french diameter is measured at the base of the tip adjacent to the sealing flange or across the diameter of the soft-bulb, beveled-tip style. these cannulae are intended for use in conjunction with cardiopulmonary bypass surgery up to six hours or less for delivery of cardioplegia solutions directly to the coronary arteries.

DLP High Flow Coronary Artery Ostial Cannulae (Models 30110, 30112, 30114, 30212) - Cannula, coronary artery Australien - engelska - Department of Health (Therapeutic Goods Administration)

dlp high flow coronary artery ostial cannulae (models 30110, 30112, 30114, 30212) - cannula, coronary artery

medtronic australasia pty ltd - 34896 - cannula, coronary artery - coronary cannulae consist of a basket-style tip, soft (silicone) tip, or spherical tip which is attached to a malleable stainless steel tube, or a soft-bulb, beveled tip with an integral silicone body. the cannulae terminate with a locking female luer fitting. the french diameter is measured at the base of the tip adjacent to the sealing flange or across the diameter of the soft-bulb, beveled-tip style. these cannulae are intended for use in conjunction with cardiopulmonary bypass surgery up to six hours or less for delivery of cardioplegia solutions directly to the coronary arteries.

Coronary optical coherence tomography system Australien - engelska - Department of Health (Therapeutic Goods Administration)

coronary optical coherence tomography system

abbott vascular division of abbott medical australia pty ltd - 47490 - coronary optical coherence tomography system - optical coherence tomography component-based system and its software used with a compatible imaging catheter is intended for qualitative and quantitative evaluation of vascular morphology in the coronary arteries, as an adjunct to conventional angiographic procedure to provide an image of vessel lumen and wall structures, for imaging of coronary arteries and is indicated in patients who are candidates for transluminal interventional procedure. the system further computes and displays various physiological parameters based on the output from one or more electrodes, transducers, or measuring devices.

ULTRAVAC SCOURSHIELD VACCINE Australien - engelska - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ultravac scourshield vaccine

zoetis australia pty ltd - bovine rotavirus g10; bovine rotavirus g6; e. coli strain - o64:k99; bovine coronavirus (inactivated); gentamicin; formaldehyde; thiomersal - misc. vaccines or anti sera - bovine rotavirus g10 active 1.0 rp/2ml d; bovine rotavirus g6 active 1.3 rp/2ml d; e. coli strain - o64:k99 vaccine-microbial active 1.0 rp/2ml d; bovine coronavirus (inactivated) vaccine-viral active 1.0 rp/2ml d; gentamicin antibiotic other 30.0 ug/ml; formaldehyde aldehyde other 0.74 mg/ml; thiomersal mercury other 0.1 mg/ml - immunotherapy - cow - pregnant | healthy pregnant heifer | bovine | pregnant cow - neonatal calf diarrhea

CORONA PLUS- hand sanitizer liquid USA - engelska - NLM (National Library of Medicine)

corona plus- hand sanitizer liquid

alternative universal medicine inc - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - purpose antiseptic

INTEGRILIN eptifibatide (as acetate) 75mg/100mL   injection vial Australien - engelska - Department of Health (Therapeutic Goods Administration)

integrilin eptifibatide (as acetate) 75mg/100ml injection vial

merck sharp & dohme (australia) pty ltd - eptifibatide, quantity: 0.75 mg/ml - injection, solution - excipient ingredients: sodium hydroxide; water for injections; citric acid monohydrate - integrilin is indicated for the treatment of patients with unstable angina or non-q-wave myocardial infarction (see clinical trials). indications as at 29 november 2001: integrilin is indicated for patients undergoing nonurgent percutaneous coronary intervention with intracoronary stenting (see clinical trials). integrilin is indicated for the treatment of patients with unstable angina or non-q-wave myocardial infarction (see clinical trials).

INTEGRILIN eptifibatide (as acetate) 20mg/10mL    injection vial Australien - engelska - Department of Health (Therapeutic Goods Administration)

integrilin eptifibatide (as acetate) 20mg/10ml injection vial

merck sharp & dohme (australia) pty ltd - eptifibatide, quantity: 2 mg/ml - injection, solution - excipient ingredients: water for injections; citric acid monohydrate; sodium hydroxide - integrilin is indicated for the treatment of patients with unstable angina or non-q-wave myocardial infarction (see clinical trials). indications as at 29 november 2001: integrilin is indicated for patients undergoing nonurgent percutaneous coronary intervention with intracoronary stenting (see clinical trials). integrilin is indicated for the treatment of patients with unstable angina or non-q-wave myocardial infarction (see clinical trials).

Severe acute respiratory syndrome-associated coronavirus IVDs Australien - engelska - Department of Health (Therapeutic Goods Administration)

severe acute respiratory syndrome-associated coronavirus ivds

allsafe medical pty ltd - ct772 - severe acute respiratory syndrome-associated coronavirus ivds - novel coronavirus (2019-ncov) nucleic acid diagnostic kit (pcr-fluorescence probing) is used for qualitative detection of the orf1ab and n genes of novel coronavirus (2019-ncov) in nasopharyngeal swab, oropharyngeal swab, alveolar lavage fluid, sputum, serum, whole blood and feces from suspected pneumonia cases with novel coronavirus infection, patients with suspected clusters of novel coronavirus infection, and other patients requiring diagnosis or differential diagnosis of novel coronavirus infection.

Severe acute respiratory syndrome-associated coronavirus IVDs Australien - engelska - Department of Health (Therapeutic Goods Administration)

severe acute respiratory syndrome-associated coronavirus ivds

emergo asia pacific pty ltd t/a emergo australia - ct772 - severe acute respiratory syndrome-associated coronavirus ivds - covid-19 coronavirus real-time pcr kit is an in vitro diagnostic (ivd) reagent replying on fluorescent pcr technology and aiming at qualitatively detect sars-cov-2 novel coronavirus from upper and lower respiratory tract samples. upper respiratory tract samples include throat swab, nasal swab, and nasopharyngeal extract. lower respiratory tract samples include sputum, respiratory tract extract, bronchial perfusate, and bronchoalveolar lavage fluid. sampling objectives include suspected cases infected by sars-cov-2, suspected cases due to crowd gathering, other cases need to be diagnosed with sars-cov-2, and other suspected environmental and biomaterials (for traceability analysis, for example). sampling should be carried out by well-trained professionals with biosafety and experimental skills. typically sars-cov-2 rna could be detected from upper and lower respiratory tract samples if a person is infected. a positive result suggests sars-cov-2 infection but bacteria and other virus-induced co-infection could not be excluded. sars-cov-2 test result is not the only confirmed evidence of suspected cases and all positive results have to be reported to the centers for disease control (cdcs) and authorities. negative results can neither straightforwardly exclude sars-cov-2 infection and nor the only decision-making evidence for treatment and patient management. a negative result should be appropriately used by combining clinical observation, medical history, and epidemiological information. the test is only available to qualified laboratories, certificated clinical pcr laboratories and 15189 certified third-party laboratories with real-time pcr thermal cyclers. operators carrying out sars-cov-2 nucleic acid testing should be well trained with laboratory biosafety and pcr experimental skills.

Quantum Dog DAPPvL+Cv Formulation:   Each dose of DAPPvLa vaccine contains:   Modified Live Virus Canine Distemper Virus (CDV) (Distemperoid Strain) >10^3.7 TCID 50/dose Modified Live Virus Canine Adenovirus Type 2 (CAV-2) (Ditchfield Strain) >10^4.8 TCID 50/dose Modified Live Virus Canine Parainfluenza (CPI) (CPI-PR Strain)- >10^4.3 TCID 50/dose Modified Live Virus Canine Parvovirus (CPV) (SAH-CPV-2b Strain) >10^5.1 TCID 50/dose Bacterin Leptospira canicola (LC-NY strain)>80 hamster PD80 Bacterin Leptospira icterohaemorrhagiae (LI-11403 J strain)>80 hamster PD80     Each dose of Canine 1-Cv vaccine contains:   Killed Virus Feline Enteric Coronavirus (FECV) (WSU 79-1683(3) strain) >1 RP/dose   TCID-Test Culture Infectious Dose FAID- Flouroscent Antibody Infect Due PD-Protective Dose RP-Relative Potency Suspension for Injection   (IM/SC) Filippinerna - engelska - FDA (Food And Drug Administration)

quantum dog dappvl+cv formulation: each dose of dappvla vaccine contains: modified live virus canine distemper virus (cdv) (distemperoid strain) >10^3.7 tcid 50/dose modified live virus canine adenovirus type 2 (cav-2) (ditchfield strain) >10^4.8 tcid 50/dose modified live virus canine parainfluenza (cpi) (cpi-pr strain)- >10^4.3 tcid 50/dose modified live virus canine parvovirus (cpv) (sah-cpv-2b strain) >10^5.1 tcid 50/dose bacterin leptospira canicola (lc-ny strain)>80 hamster pd80 bacterin leptospira icterohaemorrhagiae (li-11403 j strain)>80 hamster pd80 each dose of canine 1-cv vaccine contains: killed virus feline enteric coronavirus (fecv) (wsu 79-1683(3) strain) >1 rp/dose tcid-test culture infectious dose faid- flouroscent antibody infect due pd-protective dose rp-relative potency suspension for injection (im/sc)

msd animal health (phils), inc.; distributor: msd animal health (phils), inc. - modified live canine distemper virus (cdv) , canine adenovirus type 2 (cav-2) , canine parainfluenza virus (cpi) , canine parvovirus (cpv) , inactivated leptospira interrogans ser. canicola , leptospira interrogans ser. icterohaemorrhagiae , coronavirus vaccine (vet.) - suspension for injection (im/sc) - formulation: each dose of dappvla vaccine contains: modified live virus canine distemper virus (cdv) (distemperoid strain) >10^3.7 tcid 50/dose modified live virus canine adenovirus type 2 (cav-2) (ditchfield strain) >10^4.8 tcid 50/dose modified live virus canine parainfluenza (cpi) (cpi-pr strain)- >10^4.3 tcid 50/dose modified live virus canine parvovirus (cpv) (sah-cpv-2b strain) >10^5.1 tcid 50/dose bacterin leptospira canicola (lc-ny strain)>80 hamster pd80 bacterin leptospira icterohaemorrhagiae (li-11403 j strain)>80 hamster pd80 each dose of canine 1-cv vaccine contains: killed virus feline enteric coronavirus (fecv) (wsu 79-1683(3) strain) >1 rp/dose tcid-test culture infectious dose faid- flouroscent antibody infect due pd-protective dose rp-relative potency